Recently, we have shown that autocrine transforming growth factor-␣ (TGF-␣) controls the expression of integrin ␣ 2 , cell adhesion to collagen IV and motility in highly progressed HCT116 colon cancer cells (Sawhney, R. S., Zhou, G-H. K., Humphrey, L. E., Ghosh, P., Kreisberg, J. I., and Brattain, M. G. (2002) J. Biol. Chem. 277, 75-86). We now report that expression of basal integrin ␣ 2 and its biological effects are controlled by constitutive activation of the extracellular signal-regulated/mitogen-activated protein kinase (ERK/MAPK) pathway. Treatment of cells with selective mitogenactivated protein kinase kinase (MEK) inhibitors PD098059 and U0126 showed that integrin ␣ 2 expression, cell adhesion, and activation of ERK are inhibited in a parallel concentration-dependent fashion. Moreover, autocrine TGF-␣-mediated epidermal growth factor receptor activation was shown to control the constitutive activation of the ERK/MAPK pathway, since neutralizing antibody to the epidermal growth factor receptor was able to block basal ERK activity. TGF-␣ antisensetransfected cells also showed attenuated activation of ERK. Using a real time electric cell impedance sensing technique, it was shown that ERK-dependent integrin ␣ 2 -mediated cell micromotion signaling is controlled by autocrine TGF-␣. Thus, this study implicates ERK/MAPK signaling activated by endogenous TGF-␣ as one of the mechanistic features controlling metastatic spread.
Epidermal growth factor receptor (EGFr)1 activation is known to control cancer cell growth as a result of autocrine and/or paracrine stimulation. We have recently shown that constitutive endogenous activation of the EGFr by TGF-␣ provides a critical growth and survival advantage to colon cancer cells (1, 2). Similarly, it is conceivable that human colon cancer cells involved in metastasis may derive an advantage in cell motility from a strong autocrine TGF-␣ loop, because the initial number of cells contributing to metastatic behavior is small. Recently, we showed that in HCT116 cells, the DNA synthesis response is saturated by a relatively low EGFr occupation resulting from autocrine TGF-␣ (3). The expression level of integrin ␣ 2 and its functions, on the other hand, show a much wider window of response, increasing from low EGFr occupation by autocrine TGF-␣ to saturation by complete receptor occupation with exogenous EGF. The initiation of this response at low level receptor occupation was shown by its attenuation with treatment by an EGFr blocking antibody that inhibits basal EGFr activation resulting from autocrine TGF-␣ as well as by stable transfection with a TGF-␣ antisense cDNA to inhibit basal EGFr activation in HCT116 cells. We also observed that the addition of exogenous EGF results in further EGFr activation, which is associated with higher expression of integrin ␣ 2 , enhanced cell adhesion, and micromotility. Thus, there is a difference in response windows based on the extent of EGFr activation. While the activation of EGFr was demonstrated to be critical to ␣ 2 integrin-medi...